Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Rev Mal Respir ; 32(1): 84-6, 2015 Jan.
Artículo en Francés | MEDLINE | ID: mdl-25618211
2.
Dermatology ; 227(2): 146-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24051549

RESUMEN

Melanoma-associated retinopathy (MAR) is a rare autoimmune syndrome in patients with melanoma characterized by visual disorders. MAR is induced by the degeneration of bipolar cells of the retina and the presence of serum autoantibodies against retina proteins. Ipilimumab, an anti-cytotoxic T lymphocyte-associated antigen 4 antibody, improves survival in previously treated patients with metastatic melanoma, but is responsible for a spectrum of immune-related adverse events. Administration of ipilimumab to patients with autoimmune diseases (such as MAR or vitiligo) is actually not recommended. We report a patient presenting with MAR occurring during a melanoma relapse. Surgery and chemotherapy had no effect on visual acuity and melanoma increased. In the absence of alternative antitumoral treatment, we focused on the vital prognosis and treated the patient with ipilimumab. Two years after the treatment the patient is free from new metastasis but has presented with exacerbation of vitiligo and MAR. In the very rare case of melanoma with autoimmune disease without a therapy option, ipilimumab could be discussed, taking into account the fact that it can be effective on tumor burden but can also increase autoimmunity.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Melanoma/tratamiento farmacológico , Síndromes Paraneoplásicos Oculares/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Anciano , Autoinmunidad , Diagnóstico Diferencial , Electrorretinografía , Femenino , Angiografía con Fluoresceína , Fondo de Ojo , Humanos , Ipilimumab , Melanoma/diagnóstico , Síndromes Paraneoplásicos Oculares/diagnóstico , Síndromes Paraneoplásicos Oculares/inmunología , Neoplasias Cutáneas/diagnóstico
5.
Transpl Infect Dis ; 14(6): E147-9, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23025483

RESUMEN

Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective treatment against Enterocytozoon bieneusi, one of the two main species causing the microsporidiosis involved in human diseases. We report the first case, to our knowledge, of a probable drug-induced aseptic meningoencephalitis, after administration of fumagillin in a kidney transplant recipient with microsporidiosis.


Asunto(s)
Antifúngicos/efectos adversos , Ciclohexanos/efectos adversos , Ácidos Grasos Insaturados/efectos adversos , Trasplante de Riñón/efectos adversos , Meningoencefalitis/etiología , Microsporidiosis/tratamiento farmacológico , Ciclohexanos/uso terapéutico , Ácidos Grasos Insaturados/uso terapéutico , Femenino , Humanos , Huésped Inmunocomprometido , Persona de Mediana Edad , Sesquiterpenos/efectos adversos , Sesquiterpenos/uso terapéutico
7.
Rev Med Interne ; 33(5): e28-30, 2012 May.
Artículo en Francés | MEDLINE | ID: mdl-21821322

RESUMEN

Neutrophilic diseases may have various clinical presentations but share common histopathological manifestations with an aseptic infiltrate of polymorphonuclears neutrophils. The association with various diseases is frequent and must be systematically discussed. We report a patient who presented three different synchronous clinical manifestations of neutrophilic disease: pyoderma gangrenosum, subcorneal pustular dermatosis and aseptic spleen abscesses.


Asunto(s)
Absceso/etiología , Neutrófilos , Piodermia Gangrenosa/etiología , Enfermedades Cutáneas Vesiculoampollosas/etiología , Enfermedades del Bazo/etiología , Anciano de 80 o más Años , Humanos , Masculino , Piodermia Gangrenosa/complicaciones , Enfermedades Cutáneas Vesiculoampollosas/complicaciones , Enfermedades del Bazo/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...